Terminated PHASE4 INTERVENTIONAL 2-arm NCT00622011

Risperidone and Zotepine in the Treatment of Delirium

Sponsor: Changhua Christian Hospital

Conditions Delirium

Interventions Risperidone and Zotepine for delirium

Updated 6 times since 2017 Last updated: Feb 13, 2020 Started: Jan 31, 2008 Primary completion: Mar 31, 2009 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

inadequate participant

Other terminated trials from Changhua Christian Hospital

See all terminations from Changhua Christian Hospital

Other Delirium trials with similar outcome

Browse all Delirium trials

This PHASE4 trial investigates Delirium and is currently terminated or withdrawn. Changhua Christian Hospital leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Mar 2020 — Jan 2021 [monthly]

Terminated PHASE4

Status: Unknown Status → Terminated
Jun 2018 — Mar 2020 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changhua Christian Hospital

Data source: Changhua Christian Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Changhua, Taiwan